Jian-guang Yu

Shanghai, 200030, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 21 publications

Sinomenine attenuates post-infarction ventricular remodeling and cardiac dysfunction by suppressing α7nAChR-dependent M1 macrophage polarization and pyroptosis.

Sinomenine attenuates post-infarction ventricular remodeling and cardiac dysfunction by suppressing α7nAChR-dependent M1 macrophage polarization and pyroptosis.

Journal: International immunopharmacology

Published: May 07, 2026

Sinomenine ameliorates myocardial ischemia/reperfusion injury by inhibiting mitochondrial oxidative stress-mediated PANoptosis and ferroptosis via α7nAChR.

Sinomenine ameliorates myocardial ischemia/reperfusion injury by inhibiting mitochondrial oxidative stress-mediated PANoptosis and ferroptosis via α7nAChR.

Journal: Life sciences

Published: November 06, 2025

Cardiovascular events in crush syndrome: on-site therapeutic strategies and pharmacological investigations.

Cardiovascular events in crush syndrome: on-site therapeutic strategies and pharmacological investigations.

Journal: Frontiers in pharmacology

Published: July 30, 2024

5S management improves the service quality in the outpatient-emergency pharmacy: from management process optimisation to staff capacity enhancement.

5S management improves the service quality in the outpatient-emergency pharmacy: from management process optimisation to staff capacity enhancement.

Journal: European journal of hospital pharmacy : science and practice

Published: June 26, 2022

Case Report: Miles Surgery Ameliorates High Blood Pressure in a Rectal Carcinoma Patient With Essential Hypertension.

Case Report: Miles Surgery Ameliorates High Blood Pressure in a Rectal Carcinoma Patient With Essential Hypertension.

Journal: Frontiers in cardiovascular medicine

Published: August 23, 2021

Sinomenine in Cardio-Cerebrovascular Diseases: Potential Therapeutic Effects and Pharmacological Evidences.

Sinomenine in Cardio-Cerebrovascular Diseases: Potential Therapeutic Effects and Pharmacological Evidences.

Journal: Frontiers in cardiovascular medicine

Published: July 29, 2021

MiR-223-3p in Cardiovascular Diseases: A Biomarker and Potential Therapeutic Target.

MiR-223-3p in Cardiovascular Diseases: A Biomarker and Potential Therapeutic Target.

Journal: Frontiers in cardiovascular medicine

Published: September 26, 2020

Anisodamine Ameliorates Hyperkalemia during Crush Syndrome through Estradiol-Induced Enhancement of Insulin Sensitivity.

Anisodamine Ameliorates Hyperkalemia during Crush Syndrome through Estradiol-Induced Enhancement of Insulin Sensitivity.

Journal: Frontiers in pharmacology

Published: September 12, 2019

Protective cerebrovascular effects of hydroxysafflor yellow A (HSYA) on ischemic stroke.

Protective cerebrovascular effects of hydroxysafflor yellow A (HSYA) on ischemic stroke.

Journal: European journal of pharmacology

Published: May 03, 2017

Estrogen weakens muscle endurance via estrogen receptor-p38 MAPK-mediated orosomucoid (ORM) suppression.

Estrogen weakens muscle endurance via estrogen receptor-p38 MAPK-mediated orosomucoid (ORM) suppression.

Journal: Experimental & molecular medicine

Published: March 28, 2017

Sodium Sulfide, a Hydrogen Sulfide-Releasing Molecule, Attenuates Acute Cerebral Ischemia in Rats.

Sodium Sulfide, a Hydrogen Sulfide-Releasing Molecule, Attenuates Acute Cerebral Ischemia in Rats.

Journal: CNS neuroscience & therapeutics

Published: March 17, 2016

Activation of α7 Nicotinic Acetylcholine Receptor Decreases On-site Mortality in Crush Syndrome through Insulin Signaling-Na/K-ATPase Pathway.

Activation of α7 Nicotinic Acetylcholine Receptor Decreases On-site Mortality in Crush Syndrome through Insulin Signaling-Na/K-ATPase Pathway.

Journal: Frontiers in pharmacology

Published: January 07, 2016

Showing 1-12 of 21

Last Updated: 09/26/2026